Synapse - Hematology-Oncology Fellows

Results (1429)

Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: Characterization of a large cohort with long-term outcomes shows disparate outcomes by body region involvement

Meeting Abstract

Stuver, R.; Ghione, P.; Ganesan, N.; Noor, S.; Imber, B. S.; Pulitzer, M.; Horwitz, S. M.
Blood (2022)

Fulltext@MSK | Save

BCL6 rearranged indolent B-cell lymphomas show mutational profile similar to marginal zone lymphomas

Meeting Abstract

Galera, P. K.; Qualls, D.; Aypar, U.; Kostrzewa, C.; Zhu, M.; Baik, J.; Seshan, V.; Salles, G.; Dogan, A.
Blood (2022)

Fulltext@MSK | Save

Molecular, epigenetic, and immune landscape of TP53-mutated (TP53-M) Acute myeloid leukemia (AML) and higher risk myelodysplastic syndromes (HR-MDS)

Meeting Abstract

Bewersdorf, J. P.; Hasle, V.; Shallis, R. M.; Thompson, E. G.; de Menezes, D. L.; Rose, S.; Boss, I. W.; Halene, S.; Haferlach, T.; Fox, B.; more...
Blood (2022)

Fulltext@MSK | Save

OGDH Is a genetic vulnerability and therapeutic target in acute myeloid leukemia

Meeting Abstract

Millman, S. E.; Chaves-Perez, A.; Morris, J. P. 4th; Chen, C. C.; Ho, Y. J.; Raman, S. J.; Yashinskie, J. J.; Mezzadra, R.; Narendra, V.; Tian, S.; more...
Blood (2022)

Fulltext@MSK | Save

Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations

Meeting Abstract

DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
Blood (2022)

Fulltext@MSK | Save

Outcomes and management of SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation (HCT) and CAR-T therapy

Meeting Abstract

Infante, M. S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Politikos, I.; Barker, J. N.; Babady, N. E.; Ramanathan, L.; Seo, S.; more...
Blood (2022)

Fulltext@MSK | Save

Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy

Meeting Abstract

Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
Blood (2022)

Fulltext@MSK | Save

Safety and tolerability of pirtobrutinib monotherapy in patients with B-cell malignancies who were previously intolerant to a covalent BTK inhibitor: Results from the phase 1/2 BRUIN study

Meeting Abstract

Shah, N. N.; Wang, M. L.; Brown, J. R.; Patel, K.; Woyach, J. A.; Wierda, W. G.; Ujjani, C. S.; Eyre, T. A.; Zinzani, P. L.; Alencar, A. J.; more...
Blood (2022)

Fulltext@MSK | Save

Identifying primary refractory disease and early relapses in peripheral T-cell lymphoma using baseline characteristics, minimal residual disease, and mutational profiling

Meeting Abstract

Stuver, R.; Haynie, H.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Mazloom, A.; Moskowitz, A. J.; Drill, E.; Horwitz, S. M.
Blood (2022)

Fulltext@MSK | Save

Outcomes for patients with relapsed and refractory peripheral T-cell lymphoma in the 21st century by relapse status, salvage therapy, and receipt of allogeneic transplant

Meeting Abstract

Stuver, R.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Moskowitz, A. J.; Horwitz, S. M.
Blood (2022)

Fulltext@MSK | Save